[
  {
    "objectID": "quarto/index.html",
    "href": "quarto/index.html",
    "title": "Impact of Insurance Status on Utilization and Outcomes of Robotic-Assisted Hysterectomy Among Women With Benign Gynecologic Disease",
    "section": "",
    "text": "Reference Papers:\n\nSalman et al. 2025\n\nStudy Objective: To investigate the association between primary insurance payer status and the utilization of robotic-assisted hysterectomy (RAH) versus non-robotic approaches among women undergoing hysterectomy for benign gynecologic conditions, and postoperative outcomes specifically among those women who underwent RAH, in U.S. hospitals from 2018 to 2020.\nData Source: Cross-sectional analysis using the National Inpatient Sample (NIS) database from 2018 to 2020, a representative sample of all-payer inpatient hospitalizations in the U.S.\nPatient Selection: Included all inpatient hospitalizations for women aged 18 years and older who underwent a hysterectomy procedure, identified using ICD-10-PCS codes. Patients with diagnosis codes indicating gynecologic malignancy were excluded to focus on benign conditions. Patients were categorized based on their primary insurance payer. Hysterectomies were classified as robotic-assisted if a code for a robotic procedure was recorded in conjunction with a hysterectomy code.\nOutcomes of Interest:\n\nRoute of Hysterectomy\nIn-hospital Mortality\nLength of Stay (days)\nInflation-adjusted Total Charge ($) [adjusted to 2020 dollars, using CPI data by the U.S. Bureau of Labor Statistics]\nAny Surgical Complication (defined as a composite outcome including Postoperative Infection, Postoperative Wound Complications, or Postoperative Bleeding)\n\nStatistical Analysis: Univariable and multivariable analyses were conducted to evaluate the association between insurance status and outcomes:\n\nUnivariable Analysis:\n\nContinuous variables: Design-based Kruskal-Wallis test.\nCategorical variables: Pearson’s X² test with Rao & Scott adjustment to account for survey design.\n\nMultivariable Analysis:\n\nLogistic regression for binary outcomes (e.g., RAH utilization, in-hospital mortality, route of hysterectomy).\nLinear regression for continuous outcomes (e.g., length of stay, total charges).\n\nAdjustments: Models controlled for the following covariates:\n\nDemographics and Socioeconomic Factors: Age, Race, Residential income.\nClinical Factors: Charlson Comorbidity Index, Admission Type, specific benign gynecologic conditions (Endometriosis, Uterine Leiomyoma, Pelvic Organ Prolapse), and other comorbidities (Chronic Kidney Disease, Hypertension, Diabetes Mellitus, Previous Heart Failure, Obesity, Chronic Pulmonary Disease).\nHospital-Level Factors: Hospital region, Hospital bedsize, Hospital location and teaching status.\n\n\nSoftware: All statistical analyses were performed using R Statistical Language (Version 4.5.0; R Foundation for Statistical Computing, Vienna, Austria), incorporating survey-weighted procedures via the survey package to account for the complex sampling design of NIS."
  },
  {
    "objectID": "quarto/index.html#preamble",
    "href": "quarto/index.html#preamble",
    "title": "Impact of Insurance Status on Utilization and Outcomes of Robotic-Assisted Hysterectomy Among Women With Benign Gynecologic Disease",
    "section": "",
    "text": "Reference Papers:\n\nSalman et al. 2025\n\nStudy Objective: To investigate the association between primary insurance payer status and the utilization of robotic-assisted hysterectomy (RAH) versus non-robotic approaches among women undergoing hysterectomy for benign gynecologic conditions, and postoperative outcomes specifically among those women who underwent RAH, in U.S. hospitals from 2018 to 2020.\nData Source: Cross-sectional analysis using the National Inpatient Sample (NIS) database from 2018 to 2020, a representative sample of all-payer inpatient hospitalizations in the U.S.\nPatient Selection: Included all inpatient hospitalizations for women aged 18 years and older who underwent a hysterectomy procedure, identified using ICD-10-PCS codes. Patients with diagnosis codes indicating gynecologic malignancy were excluded to focus on benign conditions. Patients were categorized based on their primary insurance payer. Hysterectomies were classified as robotic-assisted if a code for a robotic procedure was recorded in conjunction with a hysterectomy code.\nOutcomes of Interest:\n\nRoute of Hysterectomy\nIn-hospital Mortality\nLength of Stay (days)\nInflation-adjusted Total Charge ($) [adjusted to 2020 dollars, using CPI data by the U.S. Bureau of Labor Statistics]\nAny Surgical Complication (defined as a composite outcome including Postoperative Infection, Postoperative Wound Complications, or Postoperative Bleeding)\n\nStatistical Analysis: Univariable and multivariable analyses were conducted to evaluate the association between insurance status and outcomes:\n\nUnivariable Analysis:\n\nContinuous variables: Design-based Kruskal-Wallis test.\nCategorical variables: Pearson’s X² test with Rao & Scott adjustment to account for survey design.\n\nMultivariable Analysis:\n\nLogistic regression for binary outcomes (e.g., RAH utilization, in-hospital mortality, route of hysterectomy).\nLinear regression for continuous outcomes (e.g., length of stay, total charges).\n\nAdjustments: Models controlled for the following covariates:\n\nDemographics and Socioeconomic Factors: Age, Race, Residential income.\nClinical Factors: Charlson Comorbidity Index, Admission Type, specific benign gynecologic conditions (Endometriosis, Uterine Leiomyoma, Pelvic Organ Prolapse), and other comorbidities (Chronic Kidney Disease, Hypertension, Diabetes Mellitus, Previous Heart Failure, Obesity, Chronic Pulmonary Disease).\nHospital-Level Factors: Hospital region, Hospital bedsize, Hospital location and teaching status.\n\n\nSoftware: All statistical analyses were performed using R Statistical Language (Version 4.5.0; R Foundation for Statistical Computing, Vienna, Austria), incorporating survey-weighted procedures via the survey package to account for the complex sampling design of NIS."
  },
  {
    "objectID": "quarto/index.html#baseline-table",
    "href": "quarto/index.html#baseline-table",
    "title": "Impact of Insurance Status on Utilization and Outcomes of Robotic-Assisted Hysterectomy Among Women With Benign Gynecologic Disease",
    "section": "Baseline Table:",
    "text": "Baseline Table:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOverall\nN = 343,655\nPrivate\nN = 203,700\nMedicaid\nN = 69,555\nMedicare\nN = 45,680\nOther\nN = 24,720\np-value1\n\n\n\n\nAge, y, Mean (SD)\n48 (12)\n46 (8)\n43 (9)\n65 (13)\n46 (8)\n&lt;0.001\n\n\nRace, n (%)\n\n\n\n\n\n\n\n\n\n\n&lt;0.001\n\n\n    White\n170,030 (51)\n105,485 (53)\n25,575 (38)\n29,785 (67)\n9,185 (38)\n\n\n\n\n    Asian or Pacific Islander\n14,260 (4.2)\n9,315 (4.7)\n2,700 (4.0)\n1,365 (3.1)\n880 (3.7)\n\n\n\n\n    Black\n80,145 (24)\n49,155 (25)\n17,595 (26)\n7,455 (17)\n5,940 (25)\n\n\n\n\n    Hispanic\n57,150 (17)\n27,260 (14)\n18,740 (28)\n4,610 (10)\n6,540 (27)\n\n\n\n\n    Native American\n1,845 (0.5)\n830 (0.4)\n535 (0.8)\n230 (0.5)\n250 (1.0)\n\n\n\n\n    Other\n12,645 (3.8)\n7,175 (3.6)\n2,865 (4.2)\n1,295 (2.9)\n1,310 (5.4)\n\n\n\n\nResidential income, n (%)\n\n\n\n\n\n\n\n\n\n\n&lt;0.001\n\n\n    $1 - $51,999\n102,040 (30)\n51,545 (26)\n28,295 (41)\n13,265 (29)\n8,935 (37)\n\n\n\n\n    $52,000 - $65,999\n86,500 (25)\n49,185 (24)\n19,005 (28)\n11,750 (26)\n6,560 (27)\n\n\n\n\n    $66,000 - $87,999\n81,195 (24)\n51,180 (25)\n14,125 (21)\n10,765 (24)\n5,125 (21)\n\n\n\n\n    $88,000 or more\n69,660 (21)\n49,365 (25)\n7,300 (11)\n9,290 (21)\n3,705 (15)\n\n\n\n\nHospital region, n (%)\n\n\n\n\n\n\n\n\n\n\n&lt;0.001\n\n\n    Midwest\n65,160 (19)\n40,130 (20)\n11,985 (17)\n9,710 (21)\n3,335 (13)\n\n\n\n\n    Northeast\n56,770 (17)\n33,345 (16)\n12,340 (18)\n8,380 (18)\n2,705 (11)\n\n\n\n\n    South\n147,265 (43)\n92,425 (45)\n21,965 (32)\n18,310 (40)\n14,565 (59)\n\n\n\n\n    West\n74,460 (22)\n37,800 (19)\n23,265 (33)\n9,280 (20)\n4,115 (17)\n\n\n\n\nHospital bedsize, n (%)\n\n\n\n\n\n\n\n\n\n\n&lt;0.001\n\n\n    Large\n176,580 (51)\n101,120 (50)\n36,415 (52)\n25,370 (56)\n13,675 (55)\n\n\n\n\n    Medium\n100,035 (29)\n60,155 (30)\n20,275 (29)\n12,825 (28)\n6,780 (27)\n\n\n\n\n    Small\n67,040 (20)\n42,425 (21)\n12,865 (18)\n7,485 (16)\n4,265 (17)\n\n\n\n\nHospital location and teaching status, n (%)\n\n\n\n\n\n\n\n\n\n\n&lt;0.001\n\n\n    Rural\n30,500 (8.9)\n17,420 (8.6)\n7,930 (11)\n3,045 (6.7)\n2,105 (8.5)\n\n\n\n\n    Urban, non-teaching\n61,670 (18)\n38,730 (19)\n11,890 (17)\n7,340 (16)\n3,710 (15)\n\n\n\n\n    Urban, teaching\n251,485 (73)\n147,550 (72)\n49,735 (72)\n35,295 (77)\n18,905 (76)\n\n\n\n\nCharlson Comorbidity Index, Mean (SD)\n0.54 (1.26)\n0.38 (1.01)\n0.49 (1.11)\n1.38 (2.00)\n0.44 (1.14)\n&lt;0.001\n\n\nAdmission Type, n (%)\n\n\n\n\n\n\n\n\n\n\n&lt;0.001\n\n\n    Elective\n294,210 (86)\n179,715 (89)\n55,360 (80)\n39,080 (86)\n20,055 (81)\n\n\n\n\n    Non-elective\n48,205 (14)\n23,225 (11)\n13,935 (20)\n6,435 (14)\n4,610 (19)\n\n\n\n\nEndometriosis, n (%)\n52,590 (15)\n34,595 (17)\n10,960 (16)\n3,280 (7.2)\n3,755 (15)\n&lt;0.001\n\n\nUterine Leiomyoma, n (%)\n193,975 (56)\n127,950 (63)\n36,360 (52)\n14,020 (31)\n15,645 (63)\n&lt;0.001\n\n\nPelvic Organ Prolapse, n (%)\n36,905 (11)\n16,615 (8.2)\n5,295 (7.6)\n13,285 (29)\n1,710 (6.9)\n&lt;0.001\n\n\nChronic Kidney Disease, n (%)\n7,220 (2.1)\n1,925 (0.9)\n960 (1.4)\n4,095 (9.0)\n240 (1.0)\n&lt;0.001\n\n\nHypertension, n (%)\n106,635 (31)\n54,110 (27)\n18,790 (27)\n26,825 (59)\n6,910 (28)\n&lt;0.001\n\n\nDiabetes Mellitus, n (%)\n37,625 (11)\n16,870 (8.3)\n7,945 (11)\n10,310 (23)\n2,500 (10)\n&lt;0.001\n\n\nPrevious Heart Failure, n (%)\n2,730 (0.8)\n825 (0.4)\n495 (0.7)\n1,285 (2.8)\n125 (0.5)\n&lt;0.001\n\n\nObesity, n (%)\n75,260 (22)\n43,435 (21)\n16,850 (24)\n9,985 (22)\n4,990 (20)\n&lt;0.001\n\n\nChronic Pulmonary Disease, n (%)\n37,370 (11)\n18,545 (9.1)\n8,950 (13)\n7,795 (17)\n2,080 (8.4)\n&lt;0.001\n\n\n\n1 Design-based KruskalWallis test; Pearson’s X^2: Rao & Scott adjustment"
  },
  {
    "objectID": "quarto/index.html#univariable-analysis",
    "href": "quarto/index.html#univariable-analysis",
    "title": "Impact of Insurance Status on Utilization and Outcomes of Robotic-Assisted Hysterectomy Among Women With Benign Gynecologic Disease",
    "section": "Univariable Analysis:",
    "text": "Univariable Analysis:\n\nOutcomes of patients undergoing hysterectomy:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOverall\nN = 343,655\nPrivate\nN = 203,700\nMedicaid\nN = 69,555\nMedicare\nN = 45,680\nOther\nN = 24,720\np-value1\n\n\n\n\nRoute of Hysterectomy, n (%)\n\n\n\n\n\n\n\n\n\n\n&lt;0.001\n\n\n    Abdominal\n253,095 (74)\n156,015 (77)\n52,250 (75)\n25,960 (57)\n18,870 (76)\n\n\n\n\n    Laparoscopic\n36,435 (11)\n20,190 (9.9)\n8,240 (12)\n5,080 (11)\n2,925 (12)\n\n\n\n\n    Robotic\n34,105 (9.9)\n19,195 (9.4)\n4,980 (7.2)\n8,240 (18)\n1,690 (6.8)\n\n\n\n\n    Vaginal\n20,020 (5.8)\n8,300 (4.1)\n4,085 (5.9)\n6,400 (14)\n1,235 (5.0)\n\n\n\n\n\n1 Pearson’s X^2: Rao & Scott adjustment\n\n\n\n\n\n\n\n\n\n\nOutcomes of patients undergoing robotic-assisted hysterectomy:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOverall\nN = 34,105\nPrivate\nN = 19,195\nMedicaid\nN = 4,980\nMedicare\nN = 8,240\nOther\nN = 1,690\np-value1\n\n\n\n\nLength of stay (days), Median (IQR)\n1.00 (1.00 – 3.00)\n1.00 (1.00 – 2.00)\n1.00 (1.00 – 3.00)\n2.00 (1.00 – 4.00)\n2.00 (1.00 – 3.00)\n&lt;0.001\n\n\nInflation-adjusted total charge ($), Median (IQR)\n68,863 (44,150 – 106,531)\n65,995 (42,643 – 101,313)\n70,394 (44,878 – 105,219)\n75,877 (47,901 – 120,485)\n66,397 (45,205 – 108,743)\n&lt;0.001\n\n\nAny Surgical Complication, n (%)\n630 (1.8)\n375 (2.0)\n80 (1.6)\n135 (1.6)\n40 (2.4)\n0.69\n\n\nPostoperative Infection, n (%)\n130 (0.4)\n65 (0.3)\n20 (0.4)\n30 (0.4)\n15 (0.9)\n0.46\n\n\nPostoperative Wound Complication, n (%)\n70 (0.2)\n40 (0.2)\n0 (0)\n20 (0.2)\n10 (0.6)\n0.20\n\n\nPostoperative Bleeding, n (%)\n480 (1.4)\n295 (1.5)\n65 (1.3)\n95 (1.2)\n25 (1.5)\n0.73\n\n\n\n1 Design-based KruskalWallis test; Pearson’s X^2: Rao & Scott adjustment"
  },
  {
    "objectID": "quarto/index.html#multivariable-logistic-regression",
    "href": "quarto/index.html#multivariable-logistic-regression",
    "title": "Impact of Insurance Status on Utilization and Outcomes of Robotic-Assisted Hysterectomy Among Women With Benign Gynecologic Disease",
    "section": "Multivariable Logistic Regression:",
    "text": "Multivariable Logistic Regression:\n\nRobotic-Assisted Hysterectomy:\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR (95% CI)\np-value\n\n\n\n\nExpected primary payer\n\n\n\n\n\n\n    Private\n—\n\n\n\n\n    Medicaid\n0.77 (0.70 to 0.86)\n&lt;0.001\n\n\n    Medicare\n1.19 (1.08 to 1.31)\n&lt;0.001\n\n\n    Other\n0.73 (0.64 to 0.83)\n&lt;0.001\n\n\nAge, y\n1.01 (1.01 to 1.02)\n&lt;0.001\n\n\nRace\n\n\n\n\n\n\n    White\n—\n\n\n\n\n    Asian or Pacific Islander\n0.75 (0.64 to 0.88)\n&lt;0.001\n\n\n    Black\n0.70 (0.64 to 0.77)\n&lt;0.001\n\n\n    Hispanic\n0.91 (0.82 to 1.01)\n0.071\n\n\n    Native American\n0.84 (0.55 to 1.27)\n0.40\n\n\n    Other\n1.02 (0.87 to 1.20)\n0.79\n\n\nResidential income\n\n\n\n\n\n\n    $1 - $51,999\n—\n\n\n\n\n    $52,000 - $65,999\n1.15 (1.05 to 1.26)\n0.002\n\n\n    $66,000 - $87,999\n1.25 (1.14 to 1.37)\n&lt;0.001\n\n\n    $88,000 or more\n1.38 (1.25 to 1.53)\n&lt;0.001\n\n\nHospital region\n\n\n\n\n\n\n    Midwest\n—\n\n\n\n\n    Northeast\n0.83 (0.71 to 0.96)\n0.012\n\n\n    South\n0.92 (0.82 to 1.03)\n0.16\n\n\n    West\n1.01 (0.88 to 1.16)\n0.88\n\n\nHospital bedsize\n\n\n\n\n\n\n    Large\n—\n\n\n\n\n    Medium\n1.06 (0.95 to 1.18)\n0.32\n\n\n    Small\n0.89 (0.78 to 1.02)\n0.094\n\n\nHospital location and teaching status\n\n\n\n\n\n\n    Rural\n—\n\n\n\n\n    Urban, non-teaching\n3.03 (2.10 to 4.37)\n&lt;0.001\n\n\n    Urban, teaching\n3.88 (2.73 to 5.51)\n&lt;0.001\n\n\nCharlson Comorbidity Index\n1.01 (0.99 to 1.04)\n0.26\n\n\nAdmission Type\n\n\n\n\n\n\n    Elective\n—\n\n\n\n\n    Non-elective\n1.33 (1.19 to 1.50)\n&lt;0.001\n\n\nEndometriosis\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n1.51 (1.39 to 1.64)\n&lt;0.001\n\n\nUterine Leiomyoma (Fibroids)\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n0.67 (0.63 to 0.72)\n&lt;0.001\n\n\nPelvic Organ Prolapse\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n1.58 (1.40 to 1.78)\n&lt;0.001\n\n\nChronic Kidney Disease\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n1.31 (1.12 to 1.55)\n0.001\n\n\nHypertension\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n1.01 (0.94 to 1.08)\n0.79\n\n\nDiabetes Mellitus\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n1.11 (1.02 to 1.21)\n0.020\n\n\nPrevious Heart Failure\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n1.02 (0.79 to 1.31)\n0.89\n\n\nObesity\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n1.31 (1.22 to 1.40)\n&lt;0.001\n\n\nChronic Pulmonary Disease\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n1.18 (1.09 to 1.28)\n&lt;0.001\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio\n\n\n\n\n\n\n\n\n\n\nAny Surgical Complication:\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR (95% CI)\np-value\n\n\n\n\nExpected primary payer\n\n\n\n\n\n\n    Private\n—\n\n\n\n\n    Medicaid\n0.79 (0.45 to 1.37)\n0.40\n\n\n    Medicare\n1.12 (0.63 to 1.98)\n0.71\n\n\n    Other\n1.20 (0.56 to 2.59)\n0.64\n\n\nAge, y\n0.98 (0.96 to 1.00)\n0.021\n\n\nRace\n\n\n\n\n\n\n    White\n—\n\n\n\n\n    Asian or Pacific Islander\n0.97 (0.34 to 2.79)\n0.96\n\n\n    Black\n1.19 (0.72 to 1.97)\n0.49\n\n\n    Hispanic\n0.83 (0.48 to 1.44)\n0.51\n\n\n    Native American\n0.00 (0.00 to 0.00)\n&lt;0.001\n\n\n    Other\n0.72 (0.28 to 1.90)\n0.51\n\n\nResidential income\n\n\n\n\n\n\n    $1 - $51,999\n—\n\n\n\n\n    $52,000 - $65,999\n1.47 (0.85 to 2.52)\n0.17\n\n\n    $66,000 - $87,999\n1.50 (0.86 to 2.62)\n0.16\n\n\n    $88,000 or more\n1.41 (0.78 to 2.54)\n0.25\n\n\nHospital region\n\n\n\n\n\n\n    Midwest\n—\n\n\n\n\n    Northeast\n1.27 (0.69 to 2.36)\n0.44\n\n\n    South\n1.18 (0.71 to 1.96)\n0.51\n\n\n    West\n0.94 (0.50 to 1.74)\n0.83\n\n\nHospital bedsize\n\n\n\n\n\n\n    Large\n—\n\n\n\n\n    Medium\n1.24 (0.80 to 1.90)\n0.33\n\n\n    Small\n1.49 (0.94 to 2.35)\n0.087\n\n\nHospital location and teaching status\n\n\n\n\n\n\n    Rural\n—\n\n\n\n\n    Urban, non-teaching\n0.38 (0.15 to 0.98)\n0.045\n\n\n    Urban, teaching\n0.34 (0.15 to 0.76)\n0.009\n\n\nCharlson Comorbidity Index\n1.09 (0.94 to 1.26)\n0.27\n\n\nAdmission Type\n\n\n\n\n\n\n    Elective\n—\n\n\n\n\n    Non-elective\n1.78 (1.20 to 2.65)\n0.004\n\n\nEndometriosis\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n1.02 (0.65 to 1.62)\n0.92\n\n\nUterine Leiomyoma (Fibroids)\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n0.84 (0.55 to 1.28)\n0.42\n\n\nPelvic Organ Prolapse\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n1.00 (0.57 to 1.73)\n&gt;0.99\n\n\nChronic Kidney Disease\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n1.12 (0.43 to 2.90)\n0.81\n\n\nHypertension\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n1.09 (0.70 to 1.71)\n0.70\n\n\nDiabetes Mellitus\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n1.15 (0.63 to 2.11)\n0.64\n\n\nPrevious Heart Failure\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n2.20 (0.74 to 6.51)\n0.15\n\n\nObesity\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n1.23 (0.82 to 1.84)\n0.32\n\n\nChronic Pulmonary Disease\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n0.83 (0.47 to 1.47)\n0.52\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio"
  },
  {
    "objectID": "quarto/index.html#multivariable-linear-regression",
    "href": "quarto/index.html#multivariable-linear-regression",
    "title": "Impact of Insurance Status on Utilization and Outcomes of Robotic-Assisted Hysterectomy Among Women With Benign Gynecologic Disease",
    "section": "Multivariable Linear Regression:",
    "text": "Multivariable Linear Regression:\n\nLength of Stay:\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nBeta (95% CI)\np-value\n\n\n\n\nExpected primary payer\n\n\n\n\n\n\n    Private\n—\n\n\n\n\n    Medicaid\n-0.05 (-0.30 to 0.21)\n0.72\n\n\n    Medicare\n0.37 (0.02 to 0.72)\n0.036\n\n\n    Other\n0.14 (-0.21 to 0.49)\n0.43\n\n\nAge, y\n0.01 (-0.01 to 0.02)\n0.31\n\n\nRace\n\n\n\n\n\n\n    White\n—\n\n\n\n\n    Asian or Pacific Islander\n-0.10 (-0.40 to 0.20)\n0.52\n\n\n    Black\n0.29 (0.00 to 0.58)\n0.048\n\n\n    Hispanic\n-0.18 (-0.48 to 0.11)\n0.23\n\n\n    Native American\n-0.22 (-0.78 to 0.34)\n0.44\n\n\n    Other\n-0.46 (-0.73 to -0.18)\n0.001\n\n\nResidential income\n\n\n\n\n\n\n    $1 - $51,999\n—\n\n\n\n\n    $52,000 - $65,999\n0.01 (-0.27 to 0.29)\n0.96\n\n\n    $66,000 - $87,999\n0.10 (-0.17 to 0.37)\n0.47\n\n\n    $88,000 or more\n-0.08 (-0.35 to 0.19)\n0.56\n\n\nHospital region\n\n\n\n\n\n\n    Midwest\n—\n\n\n\n\n    Northeast\n-0.01 (-0.32 to 0.30)\n0.95\n\n\n    South\n0.24 (0.01 to 0.46)\n0.038\n\n\n    West\n0.00 (-0.27 to 0.28)\n0.99\n\n\nHospital bedsize\n\n\n\n\n\n\n    Large\n—\n\n\n\n\n    Medium\n0.01 (-0.23 to 0.25)\n0.94\n\n\n    Small\n-0.14 (-0.39 to 0.11)\n0.27\n\n\nHospital location and teaching status\n\n\n\n\n\n\n    Rural\n—\n\n\n\n\n    Urban, non-teaching\n0.21 (-0.33 to 0.75)\n0.45\n\n\n    Urban, teaching\n0.29 (-0.19 to 0.78)\n0.24\n\n\nCharlson Comorbidity Index\n0.75 (0.59 to 0.92)\n&lt;0.001\n\n\nAdmission Type\n\n\n\n\n\n\n    Elective\n—\n\n\n\n\n    Non-elective\n1.8 (1.4 to 2.3)\n&lt;0.001\n\n\nEndometriosis\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n-0.10 (-0.30 to 0.10)\n0.32\n\n\nUterine Leiomyoma (Fibroids)\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n-0.34 (-0.54 to -0.15)\n&lt;0.001\n\n\nPelvic Organ Prolapse\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n-0.74 (-0.95 to -0.53)\n&lt;0.001\n\n\nChronic Kidney Disease\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n-0.65 (-1.6 to 0.34)\n0.20\n\n\nHypertension\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n0.11 (-0.12 to 0.35)\n0.34\n\n\nDiabetes Mellitus\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n-0.84 (-1.2 to -0.50)\n&lt;0.001\n\n\nPrevious Heart Failure\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n2.4 (-0.46 to 5.3)\n0.10\n\n\nObesity\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n0.25 (0.01 to 0.49)\n0.045\n\n\nChronic Pulmonary Disease\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n-0.70 (-1.0 to -0.38)\n&lt;0.001\n\n\n\nAbbreviation: CI = Confidence Interval\n\n\n\n\n\n\n\n\n\n\nInflation-adjusted Total Charge:\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nBeta (95% CI)\np-value\n\n\n\n\nExpected primary payer\n\n\n\n\n\n\n    Private\n—\n\n\n\n\n    Medicaid\n-4,487 (-12,007 to 3,033)\n0.24\n\n\n    Medicare\n763 (-4,464 to 5,989)\n0.77\n\n\n    Other\n-4,298 (-12,555 to 3,960)\n0.31\n\n\nAge, y\n324 (83 to 565)\n0.009\n\n\nRace\n\n\n\n\n\n\n    White\n—\n\n\n\n\n    Asian or Pacific Islander\n6,865 (-1,903 to 15,634)\n0.12\n\n\n    Black\n9,951 (4,147 to 15,755)\n&lt;0.001\n\n\n    Hispanic\n10,688 (3,078 to 18,298)\n0.006\n\n\n    Native American\n-12,668 (-34,326 to 8,990)\n0.25\n\n\n    Other\n2,361 (-5,327 to 10,049)\n0.55\n\n\nResidential income\n\n\n\n\n\n\n    $1 - $51,999\n—\n\n\n\n\n    $52,000 - $65,999\n5,666 (-1,645 to 12,977)\n0.13\n\n\n    $66,000 - $87,999\n2,255 (-2,853 to 7,362)\n0.39\n\n\n    $88,000 or more\n-78 (-5,811 to 5,656)\n0.98\n\n\nHospital region\n\n\n\n\n\n\n    Midwest\n—\n\n\n\n\n    Northeast\n-6,204 (-13,013 to 605)\n0.074\n\n\n    South\n18,389 (12,388 to 24,391)\n&lt;0.001\n\n\n    West\n35,817 (27,162 to 44,472)\n&lt;0.001\n\n\nHospital bedsize\n\n\n\n\n\n\n    Large\n—\n\n\n\n\n    Medium\n704 (-6,639 to 8,047)\n0.85\n\n\n    Small\n-7,806 (-14,353 to -1,259)\n0.019\n\n\nHospital location and teaching status\n\n\n\n\n\n\n    Rural\n—\n\n\n\n\n    Urban, non-teaching\n27,363 (17,105 to 37,621)\n&lt;0.001\n\n\n    Urban, teaching\n26,612 (18,720 to 34,504)\n&lt;0.001\n\n\nCharlson Comorbidity Index\n16,204 (11,273 to 21,135)\n&lt;0.001\n\n\nAdmission Type\n\n\n\n\n\n\n    Elective\n—\n\n\n\n\n    Non-elective\n26,625 (17,305 to 35,945)\n&lt;0.001\n\n\nEndometriosis\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n177 (-4,318 to 4,672)\n0.94\n\n\nUterine Leiomyoma (Fibroids)\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n-2,525 (-6,596 to 1,545)\n0.22\n\n\nPelvic Organ Prolapse\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n5,213 (-546 to 10,971)\n0.076\n\n\nChronic Kidney Disease\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n-29,688 (-49,809 to -9,566)\n0.004\n\n\nHypertension\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n-1,524 (-6,532 to 3,483)\n0.55\n\n\nDiabetes Mellitus\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n-14,409 (-21,435 to -7,384)\n&lt;0.001\n\n\nPrevious Heart Failure\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n17,879 (-7,477 to 43,234)\n0.17\n\n\nObesity\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n6,493 (668 to 12,318)\n0.029\n\n\nChronic Pulmonary Disease\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n-14,225 (-22,953 to -5,496)\n0.001\n\n\n\nAbbreviation: CI = Confidence Interval"
  }
]